Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008


  Hepatitis C

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 101 articles:
HTML format



Single Articles


    August 2008
  1. KUNTZEN T , Berical A, Ndjomou J, Bennett P, et al
    A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame.
    J Med Virol. 2008;80:1370-8.
    PubMed     Related articles    Abstract available


  2. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
    Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    J Med Virol. 2008;80:1363-9.
    PubMed     Related articles    Abstract available


  3. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
    Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
    J Med Virol. 2008;80:1354-62.
    PubMed     Related articles    Abstract available


  4. LIN A , Kadam JS, Bodenheimer HC, Leonard J, et al
    Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: A study of two cases.
    J Med Virol. 2008;80:1350-3.
    PubMed     Related articles    Abstract available


    May 2008
  5. HOSSEINI-MOGHADDAM SM , Keyvani H, Samadi M, Alavian SM, et al
    GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus.
    J Med Virol. 2008;80:1260-1263.
    PubMed     Related articles    Abstract available


  6. KAISER T , Damerow HC, Tenckhoff S, Finger A, et al
    Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: Evidence for differential viral load reduction on dialysis.
    J Med Virol. 2008;80:1195-1201.
    PubMed     Related articles    Abstract available


  7. XIA X , Lu L, Tee KK, Zhao W, et al
    The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China.
    J Med Virol. 2008;80:1142-1152.
    PubMed     Related articles    Abstract available


    April 2008
  8. MIYAZAKI M , Kanto T, Inoue M, Itose I, et al
    Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    J Med Virol. 2008;80:980-988.
    PubMed     Related articles    Abstract available


  9. CHENG PN , Wei YL, Chang TT, Chen JS, et al
    Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells.
    J Med Virol. 2008;80:989-996.
    PubMed     Related articles    Abstract available


  10. PARK SC , Jeong SH, Kim J, Han CJ, et al
    High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    J Med Virol. 2008;80:960-966.
    PubMed     Related articles    Abstract available


  11. VITALE F , Tramuto F, Orlando A, Vizzini G, et al
    Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    J Med Virol. 2008;80:577-82.
    PubMed     Related articles    Abstract available


    March 2008
  12. MARTIN C , Nielsen SU, Ibrahim S, Bassendine MF, et al
    Binding of liver derived, low density hepatitis C virus to human hepatoma cells.
    J Med Virol. 2008;80:816-823.
    PubMed     Related articles    Abstract available


  13. THONGSAWAT S , Maneekarn N, Kuniholm MH, Pantip C, et al
    Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand.
    J Med Virol. 2008;80:808-815.
    PubMed     Related articles    Abstract available


  14. CARLSSON T , Quist A, Weiland O
    Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods.
    J Med Virol. 2008;80:803-807.
    PubMed     Related articles    Abstract available


  15. MICHOS A , Terzidis A, Kalampoki V, Pantelakis K, et al
    Seroprevalence and risk factors for hepatitis A, B, and C among roma and non-roma children in a deprived area of Athens, Greece.
    J Med Virol. 2008;80:791-797.
    PubMed     Related articles    Abstract available


  16. MUERHOFF AS , Gutierrez R, Kyrk C, Leary T, et al
    Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    J Med Virol. 2008;80:411-8.
    PubMed     Related articles    Abstract available


  17. QUARANTINI LC , Miranda-Scippa A, Batista-Neves S, Galvao-de-Almeida A, et al
    The effect of early virological response in health-related quality of life in HCV-infected patients.
    J Med Virol. 2008;80:419-23.
    PubMed     Related articles    Abstract available


    February 2008
  18. NAKAMURA M , Saito H, Ikeda M, Tada S, et al
    Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment.
    J Med Virol. 2008;80:632-639.
    PubMed     Related articles    Abstract available


  19. DI LELLO F , Garcia G, Kott V, Sookoian S, et al
    Diversity of hepatitis C virus genotype 1b in Buenos Aires, Argentina: description of a new cluster associated with response to treatment.
    J Med Virol. 2008;80:619-627.
    PubMed     Related articles    Abstract available


  20. MICALESSI MI , Gerard C, Ameye L, Plasschaert S, et al
    Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
    J Med Virol. 2008;80:640-645.
    PubMed     Related articles    Abstract available


  21. PELLICANO R , Puglisi G, Ciancio A, Balzola F, et al
    Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
    J Med Virol. 2008;80:628-631.
    PubMed     Related articles    Abstract available


  22. CHLABICZ S , Flisiak R, Kowalczuk O, Wiercinska-Drapalo A, et al
    High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in North-Eastern Poland.
    J Med Virol. 2008;80:615-618.
    PubMed     Related articles    Abstract available


  23. BOUZGARROU N , Hassen E, Schvoerer E, Stoll-Keller F, et al
    Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
    J Med Virol. 2008;80:607-614.
    PubMed     Related articles    Abstract available


  24. ALZAHRANI AJ
    Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    J Med Virol. 2008;80:603-606.
    PubMed     Related articles    Abstract available


  25. PITTALUGA F , Allice T, Abate ML, Ciancio A, et al
    Clinical evaluation of the COBAS Amplipreptrade mark/COBAS TaqMantrade mark for HCV RNA quantitation in comparison with the branched-DNA assay.
    J Med Virol. 2008;80:254-60.
    PubMed     Related articles    Abstract available   Free Full Text


  26. TORRES-PUENTE M , Cuevas JM, Jimenez-Hernandez N, Bracho MA, et al
    Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    J Med Virol. 2008;80:247-53.
    PubMed     Related articles    Abstract available   Free Full Text


  27. DIAZ O , Cubero M, Trabaud MA, Quer J, et al
    Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection.
    J Med Virol. 2008;80:242-6.
    PubMed     Related articles    Abstract available   Free Full Text


  28. HU YW , Al-Moslih MI, Al Ali MT, Uzicanin S, et al
    Clinical outcome of frequent exposure to torque teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.
    J Med Virol. 2008;80:365-71.
    PubMed     Related articles    Abstract available   Free Full Text


  29. KHAN A , Kurbanov F, Tanaka Y, Elkady A, et al
    Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    J Med Virol. 2008;80:268-76.
    PubMed     Related articles    Abstract available   Free Full Text


  30. SPADA E , Abbate I, Sicurezza E, Mariano A, et al
    Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy.
    J Med Virol. 2008;80:261-7.
    PubMed     Related articles    Abstract available   Free Full Text


    December 2007
  31. BARTOLOME J , Rodriguez-Inigo E, Erice A, Vidal S, et al
    Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C.
    J Med Virol. 2007;79:1818-20.
    PubMed     Related articles    Abstract available


  32. SANDRES-SAUNE K , Abravanel F, Nicot F, Peron JM, et al
    Detection and quantitation of HCV RNA using real-time PCR after automated sample processing.
    J Med Virol. 2007;79:1821-6.
    PubMed     Related articles    Abstract available


  33. BAATEN GG , Sonder GJ, Dukers NH, Coutinho RA, et al
    Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004.
    J Med Virol. 2007;79:1802-10.
    PubMed     Related articles    Abstract available


  34. BERINI CA , Pando MA, Bautista CT, Eirin ME, et al
    HTLV-1/2 among high-risk groups in Argentina: Molecular diagnosis and prevalence of different sexual transmitted infections.
    J Med Virol. 2007;79:1914-20.
    PubMed     Related articles    Abstract available


  35. CUNHA L , Plouzeau C, Ingrand P, Gudo JP, et al
    Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    J Med Virol. 2007;79:1832-40.
    PubMed     Related articles    Abstract available


  36. PIRILLO MF , Bassani L, Germinario EA, Mancini MG, et al
    Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
    J Med Virol. 2007;79:1797-801.
    PubMed     Related articles    Abstract available


    November 2007
  37. ARRAIS TC , Van Dooren S, Vandamme AM, Brechot C, et al
    Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy-relapse or re-infection?
    J Med Virol. 2007;80:80-86.
    PubMed     Related articles    Abstract available


  38. ENGLE RE , Russell RS, Purcell RH, Bukh J, et al
    Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays.
    J Med Virol. 2007;80:72-79.
    PubMed     Related articles    Abstract available


  39. AZZARI C , Moriondo M, Indolfi G, Betti L, et al
    Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection.
    J Med Virol. 2007;80:65-71.
    PubMed     Related articles    Abstract available


  40. PEREIRA FA , da Silva NN, Rodart IF, Carmo TM, et al
    Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection.
    J Med Virol. 2007;80:58-64.
    PubMed     Related articles    Abstract available


  41. NASCIMENTO MC , Mayaud P, Sabino EC, Torres KL, et al
    Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: A multi-center serosurvey.
    J Med Virol. 2007;80:53-57.
    PubMed     Related articles    Abstract available


    October 2007
  42. VALLI MB , Crema A, Lanzilli G, Serafino A, et al
    Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.
    J Med Virol. 2007;79:1491-9.
    PubMed     Related articles    Abstract available


  43. ARASE Y , Ikeda K, Suzuki F, Suzuki Y, et al
    Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.
    J Med Virol. 2007;79:1485-90.
    PubMed     Related articles    Abstract available


    September 2007
  44. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
    Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2007;79:1686-1695.
    PubMed     Related articles    Abstract available


  45. FILIPPINI P , Coppola N, Pisapia R, Martini S, et al
    Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
    J Med Virol. 2007;79:1679-1685.
    PubMed     Related articles    Abstract available


    July 2007
  46. CARNEIRO MA , Teles SA, Lampe E, Espirito-Santo MP, et al
    Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil.
    J Med Virol. 2007;79:1325-1333.
    PubMed     Related articles    Abstract available


  47. MUDAWI HM , Smith HM, Fletcher IA, Fedail SS, et al
    Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis.
    J Med Virol. 2007;79:1322-1324.
    PubMed     Related articles    Abstract available


    June 2007
  48. ARASE Y , Ikeda K, Suzuki F, Suzuki Y, et al
    Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.
    J Med Virol. 2007;79:1095-1102.
    PubMed     Related articles    Abstract available


  49. HMAIED F , Mamou MB, Dubois M, Pasquier C, et al
    Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV.
    J Med Virol. 2007;79:1089-1094.
    PubMed     Related articles    Abstract available


  50. KINAI E , Hanabusa H, Kato S
    Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
    J Med Virol. 2007;79:1113-1119.
    PubMed     Related articles    Abstract available


  51. TOKUMOTO Y , Hiasa Y, Horiike N, Michitaka K, et al
    Hepatitis C virus expression and interferon antiviral action is dependent on PKR expression.
    J Med Virol. 2007;79:1120-1127.
    PubMed     Related articles    Abstract available


  52. ERNST E , Schonig K, Bugert JJ, Blaker H, et al
    Generation of inducible hepatitis C virus transgenic mouse lines.
    J Med Virol. 2007;79:1103-1112.
    PubMed     Related articles    Abstract available


  53. RAZAFINDRATSIMANDRESY R , Dubot A, Ramarokoto CE, Iehle C, et al
    Hepatitis C virus infection and genotypes in Antananarivo, Madagascar.
    J Med Virol. 2007;79:1082-1088.
    PubMed     Related articles    Abstract available


  54. MRANI S , Chemin I, Menouar K, Guillaud O, et al
    Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
    J Med Virol. 2007;79:1075-1081.
    PubMed     Related articles    Abstract available


  55. TSATSRALT-OD B , Takahashi M, Endo K, Agiimaa D, et al
    Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: Progress in childhood immunization.
    J Med Virol. 2007;79:1064-1074.
    PubMed     Related articles    Abstract available


  56. CHUANG WC , Sarkodie F, Brown CJ, Owusu-Ofori S, et al
    Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population.
    J Med Virol. 2007;79:724-33.
    PubMed     Related articles    Abstract available


    April 2007
  57. MORIKAWA K , Zhao Z, Date T, Miyamoto M, et al
    The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
    J Med Virol. 2007;79:714-723.
    PubMed     Related articles    Abstract available


  58. DESOMBERE I , Van Vlierberghe H, Weiland O, Hultgren C, et al
    Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C.
    J Med Virol. 2007;79:701-713.
    PubMed     Related articles    Abstract available


  59. RODRIGUEZ-TORRES M , Gonzalez-Garcia J, Brau N, Sola R, et al
    Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem?
    J Med Virol. 2007;79:694-700.
    PubMed     Related articles    Abstract available


    March 2007
  60. ITOSE I , Kanto T, Inoue M, Miyazaki M, et al
    Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.
    J Med Virol. 2007;79:511-521.
    PubMed     Related articles    Abstract available


  61. CAPA L , Soriano V, Garcia-Samaniego J, Nunez M, et al
    Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4+ and CD8+ T-cell responses to hepatitis C virus.
    J Med Virol. 2007;79:503-510.
    PubMed     Related articles    Abstract available


    February 2007
  62. MUDAWI HM , Smith HM, Rahoud SA, Fletcher IA, et al
    Epidemiology of HCV infection in Gezira state of central Sudan.
    J Med Virol. 2007;79:383-385.
    PubMed     Related articles    Abstract available


  63. TALLO T , Norder H, Tefanova V, Krispin T, et al
    Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time.
    J Med Virol. 2007;79:374-382.
    PubMed     Related articles    Abstract available


    January 2007
  64. NAPOLITANO M , Giuliani A, Alonzi T, Mancone C, et al
    Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism.
    J Med Virol. 2007;79:254-258.
    PubMed     Related articles    Abstract available


  65. CASTILLO I , Rodriguez-Inigo E, Lopez-Alcorocho JM, Bartolome J, et al
    Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    J Med Virol. 2007;79:236-241.
    PubMed     Related articles    Abstract available


  66. MOTAZAKKER M , Preikschat P, Elliott J, Smith CA, et al
    Translation efficiencies of the 5'-untranslated region of genotypes 1a and 3a in hepatitis C infected patients.
    J Med Virol. 2007;79:259-269.
    PubMed     Related articles    Abstract available


  67. THELU MA , Leroy V, Ramzan M, Dufeu-Duchesne T, et al
    IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patients.
    J Med Virol. 2007;79:242-253.
    PubMed     Related articles    Abstract available


  68. YEH CT , Chen TC, Chang ML, Hsu CW, et al
    Identification of NV-F virus DNA in hepatocellular carcinoma.
    J Med Virol. 2007;79:92-6.
    PubMed     Related articles    Abstract available


    December 2006
  69. CARRIERE M , Pene V, Breiman A, Conti F, et al
    A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication.
    J Med Virol. 2006;79:155-160.
    PubMed     Related articles    Abstract available


  70. CASTELAIN S , Bonte D, Penin F, Francois C, et al
    Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.
    J Med Virol. 2006;79:144-154.
    PubMed     Related articles    Abstract available


    November 2006
  71. THOMAS F , Nicot F, Sandres-Saune K, Dubois M, et al
    Genetic diversity of HCV genotype 2 strains in South Western France.
    J Med Virol. 2006;79:26-34.
    PubMed     Related articles    Abstract available


  72. MURAYAMA M , Katano Y, Nakano I, Ishigami M, et al
    A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b.
    J Med Virol. 2006;79:35-40.
    PubMed     Related articles    Abstract available


  73. STIKLERYTE A , Griskeviciene J, Magnius LO, Zagminas K, et al
    Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un-screened blood products in the past.
    J Med Virol. 2006;78:1411-22.
    PubMed     Related articles    Abstract available


  74. KAGEYAMA S , Agdamag DM, Alesna ET, Leano PS, et al
    A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines.
    J Med Virol. 2006;78:1423-8.
    PubMed     Related articles    Abstract available


  75. FERNANDEZ-ARCAS N , Lopez-Siles J, Trapero S, Ferraro A, et al
    High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): Phylogenetic and epidemiological analyses.
    J Med Virol. 2006;78:1429-35.
    PubMed     Related articles    Abstract available


  76. LEARY TP , Gutierrez RA, Muerhoff AS, Birkenmeyer LG, et al
    A chemiluminescent, magnetic particle-based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma.
    J Med Virol. 2006;78:1436-40.
    PubMed     Related articles    Abstract available


  77. MELLO V , Cruz T, Nunez G, Simoes MT, et al
    Peripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirin.
    J Med Virol. 2006;78:1406-10.
    PubMed     Related articles    Abstract available


    October 2006
  78. OYUNSUREN T , Kurbanov F, Tanaka Y, Elkady A, et al
    High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or Co-infection with hepatitis C, B, and delta viruses.
    J Med Virol. 2006;78:1688-1695.
    PubMed     Related articles    Abstract available


  79. TORO C , Jimenez V, Rodriguez C, Del Romero J, et al
    Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain.
    J Med Virol. 2006;78:1599-1608.
    PubMed     Related articles    Abstract available


    August 2006
  80. LI H , Liu Z, Han Q, Li Y, et al
    Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese.
    J Med Virol. 2006;78:1289-1295.
    PubMed     Related articles    Abstract available


  81. KOSMAS N , Kontos A, Panayiotakopoulos G, Dimitrakopoulos A, et al
    Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
    J Med Virol. 2006;78:1257-1261.
    PubMed     Related articles    Abstract available


  82. MANCINI N , Carletti S, Perotti M, Romano L, et al
    Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    J Med Virol. 2006;78:1304-1311.
    PubMed     Related articles    Abstract available


  83. MORICE Y , Cantaloube JF, Beaucourt S, Barbotte L, et al
    Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
    J Med Virol. 2006;78:1296-1303.
    PubMed     Related articles    Abstract available


  84. MOUTINHO RS , Perez RM, Medina-Pestana JO, Figueiredo MS, et al
    Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    J Med Virol. 2006;78:1284-1288.
    PubMed     Related articles    Abstract available


    July 2006
  85. QUIROGA JA , Llorente S, Castillo I, Rodriguez-Inigo E, et al
    Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    J Med Virol. 2006;78:1190-1197.
    PubMed     Related articles    Abstract available


  86. MOHAMED MK , Bakr I, El-Hoseiny M, Arafa N, et al
    HCV-related morbidity in a rural community of Egypt.
    J Med Virol. 2006;78:1185-1189.
    PubMed     Related articles    Abstract available


    June 2006
  87. LI C , Fu Y, Lu L, Ji W, et al
    Complete genomic sequences for hepatitis C virus subtypes 6e and 6g isolated from Chinese patients with injection drug use and HIV-1 co-infection.
    J Med Virol. 2006;78:1061-1069.
    PubMed     Related articles    Abstract available


  88. SCHVOERER E , Thumann C, Spohrer S, Soulier E, et al
    Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence.
    J Med Virol. 2006;78:1070-1075.
    PubMed     Related articles    Abstract available


  89. SUNEETHA PV , Goyal A, Hissar SS, Sarin SK, et al
    Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.
    J Med Virol. 2006;78:1055-1060.
    PubMed     Related articles    Abstract available


  90. SIMPORE J , Savadogo A, Ilboudo D, Nadambega MC, et al
    Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso.
    J Med Virol. 2006;78:730-3.
    PubMed     Related articles    Abstract available


  91. PEREIRA GA , Stefani MM, Martelli CM, Turchi MD, et al
    Human immunodeficiency virus type 1 and hepatitis C virus Co-infection and viral subtypes at an HIV testing center in Brazil.
    J Med Virol. 2006;78:719-23.
    PubMed     Related articles    Abstract available


    May 2006
  92. INDOLFI G , Azzari C, Moriondo M, Lippi F, et al
    Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission.
    J Med Virol. 2006;78:911-914.
    PubMed     Related articles    Abstract available


    April 2006
  93. DELWART E , Kuhns MC, Busch MP
    Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: Implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    J Med Virol. 2006;78.
    PubMed     Related articles    Abstract available


  94. DI BISCEGLIE AM , Fan X, Chambers T, Strinko J, et al
    Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: the null responder.
    J Med Virol. 2006;78:446-51.
    PubMed     Related articles    Abstract available


    March 2006
  95. ZHOU DX , Tang JW, Chu IM, Cheung JL, et al
    Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong.
    J Med Virol. 2006;78:574-581.
    PubMed     Related articles    Abstract available


  96. HOSSEINI-MOGHADDAM SM , Keyvani H, Kasiri H, Kazemeyni SM, et al
    Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran-a multicenter study.
    J Med Virol. 2006;78:569-573.
    PubMed     Related articles    Abstract available


  97. TSATSRALT-OD B , Takahashi M, Endo K, Buyankhuu O, et al
    Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    J Med Virol. 2006;78:542-550.
    PubMed     Related articles    Abstract available


  98. COLLENBERG E , Ouedraogo T, Ganame J, Fickenscher H, et al
    Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    J Med Virol. 2006;78:683-692.
    PubMed     Related articles    Abstract available


    January 2006
  99. VRAY M , Debonne JM, Sire JM, Tran N, et al
    Molecular epidemiology of hepatitis B virus in Dakar, Senegal.
    J Med Virol. 2006;78:329-334.
    PubMed     Related articles    Abstract available


  100. MUERHOFF AS , Dawson GJ, Desai SM
    A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5'-untranslated region sequences.
    J Med Virol 2006;78:105-111.
    PubMed     Related articles    Abstract available


  101. LIN JB , Lin DB, Chen SC, Chen PS, et al
    Seroepidemiology of hepatitis A, B, C, and E viruses infection among preschool children in Taiwan.
    J Med Virol 2006;78:18-23.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: